Cumberland Pharmaceuticals (CPIX)

• Market cap: $78.4M
• 1 day: -10.58%
• 5 days: -11.19%
• 1 month: -5.76%
• 3 months: -4.55%
• 6 months: 120.17%
• Year to date: 134.98%
• 1 year: 238.06%
• 5 years: 56.89%
• 10 years: -29.09%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Employees: 91

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

3,038% more call options, than puts

Call options by funds: $1M | Put options by funds: $32K

1,300% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 1

316% more capital invested

Capital invested by funds: $4.36M [Q4 2024] → $18.1M (+$13.8M) [Q1 2025]

65% more funds holding

Funds holding: 20 [Q4 2024] → 33 (+13) [Q1 2025]

17.52% more ownership

Funds ownership: 13.12% [Q4 2024] → 30.64% (+17.52%) [Q1 2025]

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8